Toews Corporation’s Pfizer PFE Stock Holding History

Toews Corporation’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24,500	Closed	-$813K	–	88
2023 Q3	$813K	Buy	+24,500	New	+$866K	0.49%	2
2021 Q4	–	Sell	-9,500	Closed	-$409K	–	100
2021 Q3	$409K	Buy	+9,500	New	+$421K	0.05%	63
2021 Q2	–	Sell	-26,100	Closed	-$946K	–	93
2021 Q1	$946K	Buy	+26,100	New	+$927K	0.08%	55
2020 Q4	–	Sell	-28,563	Closed	-$995K	–	94
2020 Q3	$995K	Buy	+28,563	New	+$1M	0.3%	50
2019 Q1	–	Sell	-25,823	Closed	-$1.07M	–	82
2018 Q4	$1.07M	Buy	+25,823	New	+$1.07M	0.46%	37
2018 Q3	–	Sell	-11,172	Closed	-$385K	–	80
2018 Q2	$385K	Sell	11,172 -17,813	-61%	-$609K	0.09%	48
2018 Q1	$976K	Buy	+28,985	New	+$996K	0.32%	30

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Toews Corporation's PFE Position: Q4 2023 in Review

Toews Corporation sold out of Pfizer (PFE) in Q4 2023, closing a stake of 24,500 shares — an estimated $813K sold.

Toews Corporation first reported a position in PFE in Q1 2018 and held it in 7 quarters. The position peaked at $1.07M in Q4 2018. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

Toews Corporation reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
Toews Corporation sold 24,500 Pfizer shares in Q4 2023, an estimated $813K.
Toews Corporation first reported a position in Pfizer in Q1 2018 and held it in 7 quarters.
Toews Corporation's Pfizer position peaked at $1.07M in Q4 2018.
2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on Toews Corporation's 13F filing for Q4 2023, filed 17 Jan 2024.